| Code | 51866 | ||||||||||
| MA number | 14/0151/08-S | ||||||||||
| Product Form: | tbl mnd 90x4 mg (blis.Al/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 14 - BRONCHODILATANTIA, ANTIASTHMATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister Al/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 24.07.2008 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| PIL: |
PIL_Montelukast Teva 4mg_12_2022.pdf
|
| SPC: |
SPC_Montelukast Teva 4mg_12_2022.pdf
|
| Safety feature | Yes |
| Data update: | 08.03.2018 |
